At a glance
- Originator Nippon Kayaku
- Class Acetamides; Ischaemic heart disorder therapies; Pyrimidines
- Mechanism of Action Chymase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders